Home » Topics » BioWorld Science

BioWorld Science
RSS

ReViral patents respiratory syncytial virus fusion inhibitors

July 12, 2019

Roche discloses new gamma-secretase inhibitors

July 12, 2019

NodThera discovers NLRP3 inflammasome inhibitors

July 12, 2019

New adenosine A2A receptor antagonists presented by Adorx Therapeutics

July 12, 2019

Lundbeck describes new PDE1 inhibitors

July 12, 2019

Hydra's opposite: researchers identify broad resistance mechanism to narrowly targeted therapies

July 12, 2019

CEPI and WBVR partner on vaccine for Rift Valley fever

July 12, 2019

NDFIP1 may be a novel target for prevention and treatment of Parkinson's disease

July 12, 2019

Tracer quantification and assessment of tumor uptake of [18F]afatinib in NSCLC

July 12, 2019

[89Zr]-Daratumumab as a promising new agent for CD38-targeted imaging of myeloma

July 12, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...